News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
319,850 Results
Type
Article (17381)
Company Profile (295)
Press Release (302173)
Multimedia
Podcasts (62)
Webinars (10)
Section
Business (95180)
Career Advice (210)
Deals (16747)
Drug Delivery (43)
Drug Development (57113)
Employer Resources (40)
FDA (6747)
Job Trends (6440)
News (170927)
Policy (11966)
Tag
Academia (994)
Accelerated approval (4)
Adcomms (14)
Allergies (64)
Alliances (24656)
ALS (88)
Alzheimer's disease (981)
Antibody-drug conjugate (ADC) (137)
Approvals (6798)
Artificial intelligence (167)
Autoimmune disease (33)
Automation (6)
Bankruptcy (121)
Best Places to Work (5559)
BIOSECURE Act (7)
Biosimilars (70)
Biotechnology (240)
Bladder cancer (74)
Brain cancer (29)
Breast cancer (241)
Cancer (2157)
Cardiovascular disease (156)
Career advice (186)
Career pathing (5)
CAR-T (164)
CDC (5)
Cell therapy (434)
Cervical cancer (13)
Clinical research (47358)
Collaboration (760)
Company closure (2)
Compensation (428)
Complete response letters (15)
COVID-19 (1184)
CRISPR (62)
C-suite (246)
Cystic fibrosis (100)
Data (2326)
Decentralized trials (1)
Denatured (12)
Depression (47)
Diabetes (209)
Diagnostics (2027)
Digital health (5)
Diversity (4)
Diversity, equity & inclusion (10)
Drug discovery (113)
Drug pricing (40)
Drug shortages (5)
Duchenne muscular dystrophy (121)
Earnings (38847)
Editorial (20)
Employer branding (8)
Employer resources (37)
Events (58404)
Executive appointments (592)
FDA (7809)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (676)
Gene editing (134)
Generative AI (13)
Gene therapy (336)
GLP-1 (513)
Government (1246)
Grass and pollen (2)
Guidances (107)
Healthcare (7731)
Huntington's disease (30)
IgA nephropathy (42)
Immunology and inflammation (134)
Immuno-oncology (5)
Indications (28)
Infectious disease (1277)
Inflammatory bowel disease (128)
Inflation Reduction Act (9)
Influenza (30)
Intellectual property (89)
Interviews (23)
IPO (9013)
IRA (20)
Job creations (1227)
Job search strategy (173)
Kidney cancer (8)
Labor market (14)
Layoffs (330)
Leadership (6)
Legal (1726)
Liver cancer (49)
Lung cancer (303)
Lymphoma (165)
Machine learning (8)
Management (10)
Manufacturing (218)
MASH (85)
Medical device (3166)
Medtech (3167)
Mergers & acquisitions (8234)
Metabolic disorders (576)
Multiple sclerosis (76)
NASH (14)
Neurodegenerative disease (98)
Neuropsychiatric disorders (33)
Neuroscience (1539)
NextGen: Class of 2025 (2313)
Non-profit (979)
Now hiring (24)
Obesity (281)
Opinion (130)
Ovarian cancer (91)
Pain (57)
Pancreatic cancer (90)
Parkinson's disease (158)
Partnered (10)
Patents (203)
Patient recruitment (122)
Peanut (40)
People (29767)
Pharmaceutical (52)
Pharmacy benefit managers (6)
Phase I (16368)
Phase II (21870)
Phase III (14423)
Pipeline (1339)
Policy (76)
Postmarket research (959)
Preclinical (6784)
Press Release (32)
Prostate cancer (97)
Psychedelics (40)
Radiopharmaceuticals (253)
Rare diseases (392)
Real estate (1756)
Recruiting (16)
Regulatory (10483)
Reports (19)
Research institute (1024)
Resumes & cover letters (24)
Rett syndrome (8)
RNA editing (10)
RSV (18)
Schizophrenia (82)
Series A (133)
Series B (85)
Service/supplier (2)
Sickle cell disease (56)
Special edition (13)
Spinal muscular atrophy (122)
Sponsored (14)
Startups (2216)
State (1)
Stomach cancer (5)
Supply chain (30)
Tariffs (20)
The Weekly (49)
Vaccines (355)
Venture capital (46)
Weight loss (149)
Women's health (23)
Worklife (2)
Date
Last 7 days (260)
Last 30 days (1236)
Last 365 days (21518)
2025 (11618)
2024 (23720)
2023 (26007)
2022 (31455)
2021 (32380)
2020 (27256)
2019 (19206)
2018 (14147)
2017 (16684)
2016 (14150)
2015 (17049)
2014 (12164)
2013 (8702)
2012 (8919)
2011 (9166)
2010 (8903)
Location
Africa (196)
Alabama (52)
Alaska (2)
Arizona (65)
Arkansas (5)
Asia (21121)
Australia (3626)
California (5398)
Canada (1488)
China (544)
Colorado (186)
Connecticut (212)
Delaware (152)
Europe (46211)
Florida (662)
Georgia (167)
Hawaii (1)
Idaho (18)
Illinois (310)
India (13)
Indiana (154)
Iowa (7)
Japan (162)
Kansas (66)
Kentucky (6)
Louisiana (4)
Maine (11)
Maryland (632)
Massachusetts (4294)
Michigan (93)
Minnesota (182)
Mississippi (2)
Missouri (33)
Montana (16)
Nebraska (4)
Nevada (26)
New Hampshire (14)
New Jersey (1444)
New Mexico (15)
New York (1450)
North Carolina (674)
North Dakota (6)
Northern California (2459)
Ohio (140)
Oklahoma (10)
Oregon (22)
Pennsylvania (974)
Puerto Rico (9)
Rhode Island (22)
South America (274)
South Carolina (8)
Southern California (2010)
Tennessee (34)
Texas (672)
United States (18385)
Utah (92)
Virginia (116)
Washington D.C. (43)
Washington State (451)
West Virginia (1)
Wisconsin (52)
319,850 Results for "pipeline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics
May 27, 2025
·
5 min read
Press Releases
Imbrium Therapeutics to Showcase Pipeline Assets Open for Partnership at the BIO International Convention 2025
June 16, 2025
·
3 min read
Press Releases
Hemab Therapeutics Presents Positive Clinical and Preclinical Data Across Bleeding Disorder Pipeline at ISTH 2025 Congress
June 25, 2025
·
9 min read
Press Releases
Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor
June 4, 2025
·
6 min read
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral sclerosis, coming less than a year after the pharma licensed QurAlis’ antisense oligonucleotide to correct a specific protein alteration in ALS.
May 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results
May 8, 2025
·
15 min read
Press Releases
BRENIG THERAPEUTICS ANNOUNCES APPOINTMENTS OF DAVID L. LUCCHINO AS CEO AND TIEN DAM, M.D., AS CHIEF MEDICAL OFFICER, EXPANDS PIPELINE
July 11, 2025
·
4 min read
Press Releases
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
May 12, 2025
·
12 min read
Press Releases
CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline
June 26, 2025
·
8 min read
Press Releases
ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress
May 12, 2025
·
10 min read
1 of 31,985
Next
